Transformative Business Strategies

To drive growth and navigate the evolving life sciences landscape effectively.

Market Access Solutions

Creating strategies for pricing and reimbursement to enhance market access and stakeholder value.

Real-World Evidence

Holistic strategies to communicate value and support decision-making among key stakeholders.

Growth Catalysts

Identifying impactful activities to outperform competitors and accelerate business growth in life sciences.

Globally Renown Life Sciences Expert

A distinguished expert in the Life sciences sector, with over a decade of experience in executive leadership roles at national, international, and global organizations. His unique blend of legal, medical, and business acumen makes him an invaluable asset in navigating the complex landscape of healthcare and pharmaceutical industries.

Key Expertise

Sarunas has been advising over a dozen of global pharmaceutical companies on strategic initiatives, has been working with inter-governmental organisations, represented governments, multi-stakeholder platforms and has been shaping cancer policies for the past 15 years. Narbutas has demonstrated exceptional skills in business strategy development and implementation, multi-stakeholder leadership across diverse teams and cultures, patient engagement and advocacy, real-world evidence generation and utilization, market access and reimbursement strategies. His experience spans five continents, showcasing his ability to operate effectively in global markets and diverse cultural contexts.

Sarunas has an impressive portfolio of achievements:

• Led and coordinated over 10 international projects funded under EU4Health, Horizon Europe, and IHI programs.

• Managed more than 20 national projects funded through government grants and EU Joint Action initiatives.

• Co-authored several legal monographs and research papers in medical law and life sciences.

• Facilitated or spoken at over 300 international events.

• Conducted more than 500 media interviews.

• Served on numerous advisory boards for organizations like the British Medical Journal, The Economist and European Organisation for Research and Treatment of Cancer (EORTC).

Your Partner in Growth

Sarunas's unique combination of skills, experience, and influence makes him the ideal partner for organizations seeking to navigate the challenges and opportunities in the ever-evolving life sciences sector.

Sarunas Narbutas

Founding Team

A Visionary in Life Sciences Business Development

A dynamic and results-driven business development leader with over 7 years of experience at the forefront of life sciences investments. Her career has been marked by a proven ability to foster strategic partnerships, drive multi-million-euro investment projects, and deliver impactful outcomes for the biotech, pharma, and medical device industries.

Key Expertise

Your Partner in Growth

Whether you're looking to expand globally, secure strategic partnerships, or navigate the complexities of life sciences investment landscapes, Karolina's unparalleled experience and results-oriented approach make her the ideal collaborator to achieve your goals.

Karolina Karl

• Strategic Leadership: Karolina has a history of leading high-performing sales, implementing innovative market-entry strategies, and building robust pipelines to unlock growth opportunities. She has successfully directed sales teams and spearheaded Lithuania's entry strategy into the U.S. life sciences market.

• Business Development & Partnerships: A skilled negotiator and relationship builder, Karolina has collaborated with global leaders such as Takeda, Pfizer, Merck, Thermo Fisher Scientific, Moderna, and many others. Her expertise lies in bridging groundbreaking therapies with leading developers, securing pivotal out-licensing agreements, and crafting tailored solutions to meet client objectives.

• Impactful engagement: As a driving force behind Lithuania's Life Sciences Roadmap 2030, Karolina has positioned the country as a competitive player on the global stage. She has represented Lithuania at major conferences, contributed to panel discussions, and gained international recognition in publications like Drug Discovery World, Manufacturing Chemist and others.

Regulatory Affairs and Future-Proofing Professional

Justina has over 17 years of experience in the healthcare industry and life sciences. As Head of the Health Care Innovations Development Centre at the Lithuanian University of Health Sciences, she facilitated collaboration with the largest medical academic team in the Baltics, leading to new products, start-ups, and spin-offs with high commercial potential. Previously, she held key positions at the Ministry of Health of Lithuania, overseeing the development and deployment of the national e-health system, connecting over 40 national information systems and registries. She also introduced and implemented the HTA model in public and personal health, managed healthcare professionals' supply and demand, supervised the quality and safety of healthcare services, and analysed and implemented cross-border EU healthcare policies. As a representative of the Ministry of Health at various EU task forces, working groups, and boards, Justina was actively involved in EU legislation, policy dialogues, and expert networking.

Key Expertise

• Regulatory Affairs – practical cases-based excellence in the regulatory environment of medical devices and pharmaceuticals, including market supervision requirements for complex biological medicinal products.

• Reimbursement and payers – full assistance to bring your product to the next level of market reach.

• Academic background – Justina has a background in law. As a PhD candidate of Law, she dedicated her academic research and publications for biomedical law and health data.

Your Partner in Growth

Justina is a go-to partner due to her extensive experience in healthcare, leadership in innovation, and active involvement in EU healthcare policy and legislation.

Justina Januseviciene

Our Services

Business strategy

• Develop comprehensive transformation / culture change strategies to address challenges in the rapidly evolving Life Sciences landscape.

• Identify and prioritize impactful activities to catalyse business growth and outperform sector competitors.

Reimbursement - PICO models

• Navigate the complexities of consolidated PICOs across EU Member States for joint clinical assessments.

• Develop strategies to manage potentially unmanageable numbers of PICOs due to varying definition of standard of care and patient sub-populations.

Market access

• Create holistic, cross-functional real-world evidence strategies to effectively communicate value to stakeholders.

• Develop pricing, reimbursement and market access strategies that balance the needs of critical stakeholders.

Network building

• Facilitate the consolidation of independent clinical trial sites into larger, integrated networks.

• Develop strategies for building stronger, more transparent relationships between stakeholders at national, pan-Baltic, CEE or pan-European level..

Patient engagement

• Develop and implement company-wide or disease-specific patient-centric engagement strategies tailored to national, pan-Baltic, CEE, pan-European culture.

• Create effective patient education and support toolkits, action plans with a focus on health literacy, EDI practices, capacity building.

Culture change

• Implement strategies to reverse lagging patient engagement practices within the company.

• Conduct trainings to the workforce on emerging trends in patient engagement, patient advocacy, health policy, legal and compliance matters.

Global trend insights

• Analyse emerging markets and shifting population trends to identify new opportunities for Life Science companies.

• Provide insights on regulatory changes and their impact on drug development and market access strategies.

Real-world evidence generation

• Design and implement real-world evidence strategies to support regulatory approval, market access and post-marketing authorisation needs.

• Develop data strategies to identify priority use cases, obtain datasets, and leverage partnerships for evidence generation.

Guidance on financial regulatory environment

• Tailored value propositions for market entry - crafting bespoke value propositions for expansion projects, evaluating all site selection criteria such as infrastructure, technology, cost advantage, talent pool and other.

• Regulatory framework guidance - advising on legal and fiscal environments to align with global and local standards.

Sector-specific guidance

• GMP, CMC, ATMP - providing insights into Good Manufacturing Practices (GMP) local set-up, and Advanced Therapy Medicinal Products (ATMP) trends, finding key experts on specific technology or processes.

• Guidance on the Clinical Trials in the EU - connecting with local and foreign experts to deliver desirable client outcomes.

Multi-stakeholder leadership

• Facilitate alignment and communication between diverse stakeholders at national, pan-Baltic, CEE and pan-European level.

• Create and lead multi-stakeholder initiatives, consortiums, platforms.

Financial growth

• Investment attraction across different stages in pharmaceuticals, biotech fields.

• Mergers and acquisitions - finding the right partner, negotiating and finalizing agreements.

Global representation

• Networking - on behalf of the client establishing connecting with key opinion leaders, industry players, and other leaders to drive the company’s growth.

• International representation - representing clients at international conferences, panels, and thought leadership forums, connecting with specific media to increase visibility and reach sales targets.

Market research

• Conducting in-depth analysis to identify and understand target groups, which include users and payers, to tailor health tech solutions effectively.

• Providing comprehensive market access recommendations that are both focused and feasible, ensuring the successful entry and sustainability of health tech products in the market.

Biotech regulations (Eudralex)

• Guidance on EMA legal framework for starting materials of pharmaceuticals (including biologicals).

• Assistance for preparation of GMP compliance documentation.

Piloting projects

• Building up and management of biomedical research projects or other proof of concept (POC) projects to collect determined Real World Data (RWD) and Real World Evidence (RWE).

• Implementation of pilot projects to evaluate new healthcare services and service provision models in diverse settings.

Medtech regulations (MDR)

• Comprehensive consultation on MDR requirements for all classes of medical devices

• Consultations on post market surveillance.

Biomedical research design

• Assistance on building up and implementation of a biomedical research.

• Guidance on the design and implementation of biomedical research projects to ensure robust data collection and analysis.

Bioethics

• Guidance on ethical considerations in biomedical research, ensuring compliance with regulatory standards and safeguarding patient rights.

• Support for the secondary use of data, including consent management and ethical review processes to maintain data integrity and privacy.

HTA & Reimbursement

• Building solid clinical and health economic evidence to support Health Technology Assessment (HTA) submissions and secure reimbursement for new healthcare interventions.

• Providing comprehensive evidence to payers to demonstrate the value and effectiveness of healthcare services and ensure their inclusion in reimbursement schemes.

Where We Excel at Exceeding Your Expectations

Our Services

Where we excel at exceeding your expectations

Business strategy

Market access

Patient engagement

Reimbursement – PICO models

Network building

Culture change

Global trend insights

• Analyse emerging markets and shifting population trends to identify new opportunities for Life Science companies.

• Provide insights on regulatory changes and their impact on drug development and market access strategies.

Multi-stakeholder leadership

• Facilitate alignment and communication between diverse stakeholders at national, pan-Baltic, CEE and pan-European level.

• Create and lead multi-stakeholder initiatives, consortiums, platforms.

Real World Evidence generation

• Design and implement real-world evidence strategies to support regulatory approval, market access and post-marketing authorisation needs.

• Develop data strategies to identify priority use cases, obtain datasets, and leverage partnerships for evidence generation.

Financial growth

• Investment attraction across different stages in pharmaceuticals, biotech fields.

• Mergers and acquisitions - finding the right partner, negotiating and finalizing agreements.

Guidance on financial regulatory environment

• Tailored value propositions for market entry - crafting bespoke value propositions for expansion projects, evaluating all site selection criteria such as infrastructure, technology, cost advantage, talent pool and other.

• Regulatory framework guidance - advising on legal and fiscal environments to align with global and local standards.

Global representation

• Networking - on behalf of the client establishing connecting with key opinion leaders, industry players, and other leaders to drive the company’s growth.

• International representation - representing clients at international conferences, panels, and thought leadership forums, connecting with specific media to increase visibility and reach sales targets.

Industry-specific guidance

• GMP, CMC, ATMP - providing insights into Good Manufacturing Practices (GMP) local set-up, and Advanced Therapy Medicinal Products (ATMP) trends, finding key experts on specific technology or processes.

• Guidance on the Clinical Trials in the EU - connecting with local and foreign experts to deliver desirable client outcomes.

Medtech regulations (MDR)

• Comprehensive consultation on MDR requirements for all classes of medical devices

• Consultations on post market surveillance.

Biotech regulations (Eudralex)

• Guidance on EMA legal framework for starting materials of pharmaceuticals (including biologicals).

• Assistance for preparation of GMP compliance documentation.

Market research

• Conducting in-depth analysis to identify and understand target groups, which include users and payers, to tailor health tech solutions effectively.

• Providing comprehensive market access recommendations that are both focused and feasible, ensuring the successful entry and sustainability of health tech products in the market.

Piloting projects

• Building up and management of biomedical research projects or other proof of concept (POC) projects to collect determined Real World Data (RWD) and Real World Evidence (RWE).

• Implementation of pilot projects to evaluate new healthcare services and service provision models in diverse settings.

Biomedical research design

• Assistance on building up and implementation of a biomedical research.

• Guidance on the design and implementation of biomedical research projects to ensure robust data collection and analysis.

Bioethics

• Guidance on ethical considerations in biomedical research, ensuring compliance with regulatory standards and safeguarding patient rights.

• Support for the secondary use of data, including consent management and ethical review processes to maintain data integrity and privacy.

HTA & Reimbursement

• Building solid clinical and health economic evidence to support Health Technology Assessment (HTA) submissions and secure reimbursement for new healthcare interventions.

• Providing comprehensive evidence to payers to demonstrate the value and effectiveness of healthcare services and ensure their inclusion in reimbursement schemes.